Idiopathic intracranial hypertension

被引:74
作者
Dhungana, S. [1 ]
Sharrack, B. [1 ]
Woodroofe, N. [2 ]
机构
[1] Univ Sheffield, Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England
[2] Sheffield Hallam Univ, Sheffield S1 1WB, S Yorkshire, England
来源
ACTA NEUROLOGICA SCANDINAVICA | 2010年 / 121卷 / 02期
关键词
idiopathic intracranial hypertension; review; pathogenesis; SYSTEMIC LUPUS-ERYTHEMATOSUS; PSEUDOTUMOR CEREBRI SYNDROME; CEREBROSPINAL-FLUID DIVERSION; NERVE SHEATH DECOMPRESSION; TRANSVERSE SINUS STENOSES; POLYCYSTIC-OVARY-SYNDROME; L-THYROXINE THERAPY; INDUCED WEIGHT-LOSS; MR VENOGRAPHY; TUMOR CEREBRI;
D O I
10.1111/j.1600-0404.2009.01172.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Idiopathic intracranial hypertension (IIH) is a condition which affects predominantly overweight women and is characterized by raised intracranial pressure without any identifiable pathology in the brain and with normal cerebrospinal fluid (CSF) composition. The cause of IIH is unclear and as such it remains a diagnosis of exclusion. Although the pathophysiology of IIH remains elusive, some observations have recently been added to our understanding of this, including the presence of transverse sinus stenosis on many patients and the possible role of leptin and inflammation in the disease pathogenesis. Headache is the most common symptom and papilloedema is the major clinical finding. Choices of medical treatment are limited to the use of diuretics particularly acetazolamide and encouragement of weight loss. Surgical therapies such as CSF diversion procedures and fenestration of the optic nerve may be necessary in some cases with persistent symptoms or progressive visual deterioration. While not life-threatening, IIH has a significant morbidity with up to 25% of patients developing visual impairment from optic atrophy. Visual surveillance is therefore vital. Long-term follow-up is recommended as the disease may worsen after an initial period of stability.
引用
收藏
页码:71 / 82
页数:12
相关论文
共 136 条
[1]   Stereotactic ventriculoperitoneal shunting for refractory idiopathic intracranial hypertension [J].
Abu-Serieh, Basel ;
Ghassempour, Keyvan ;
Duprez, Thierry ;
Raftopoulos, Christian .
NEUROSURGERY, 2007, 60 (06) :1039-1043
[2]   MR-intracranial pressure (ICP): A method to measure intracranial elastance and pressure noninvasively by means of MR imaging: Baboon and human study [J].
Alperin, NJ ;
Lee, SH ;
Loth, F ;
Raksin, PB ;
Lichtor, T .
RADIOLOGY, 2000, 217 (03) :877-885
[3]  
AMARAL JF, 1987, ARCH SURG-CHICAGO, V122, P946
[4]  
Ayanzen RH, 2000, AM J NEURORADIOL, V21, P74
[5]  
Backhouse O, 1998, BRIT J OPHTHALMOL, V82, P844
[6]   Familial thrombophilia and idiopathic intracranial hypertension [J].
Backhouse, OC ;
Johnson, M ;
Jamieson, DR ;
Menage, MJ ;
Goulding, PJ ;
McVerry, BA ;
Cawthray, N .
NEURO-OPHTHALMOLOGY, 2001, 25 (03) :135-141
[7]  
BALL AK, 2008, CLIN ENDOCRINOL 0902
[8]   Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study [J].
Bastin, ME ;
Sinha, S ;
Farrall, AJ ;
Wardlaw, JM ;
Whittle, IR .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (12) :1693-1696
[9]  
Bedford THB, 1935, BRAIN, V58, P426
[10]   Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension [J].
Bicakci, K. ;
Bicakci, S. ;
Aksungur, E. .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (03) :193-197